PremiumCompany AnnouncementsBotanix Pharmaceuticals Announces Quotation of New Securities on ASX Botanix Pharmaceuticals Reports Increased Losses Amidst Revenue Decline Botanix Pharmaceuticals’ Chair Adjusts Shareholding Amidst Strategic Growth PremiumCompany AnnouncementsShenasaby Investments Ceases to be Substantial Holder in Botanix Pharmaceuticals Botanix Pharmaceuticals Prepares for Sofdra™ Market Launch Botanix Pharmaceuticals: Director’s Stock Interests Surge PremiumCompany AnnouncementsBotanix Pharmaceuticals Expands Sofdra™ Coverage in US Botanix Pharmaceuticals Passes Key AGM Resolutions Botanix Pharmaceuticals: Strong Leadership Fuels Market Potential